IL-17 accelerates the development of IDD by promoting the degradation of the extracellular matrix, enhancing the inflammatory response, inducing neo-angiogenesis, and inhibiting autophagy and NP cell proliferation. Here, IL17A is linked to intervertebral disk degenerative disorder.